SALVESTRINI, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.692
AS - Asia 2.276
EU - Europa 1.514
AF - Africa 131
SA - Sud America 103
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.723
Nazione #
US - Stati Uniti d'America 2.652
VN - Vietnam 764
SG - Singapore 539
CN - Cina 486
GB - Regno Unito 368
IT - Italia 222
SE - Svezia 213
DE - Germania 185
HK - Hong Kong 116
IN - India 104
FR - Francia 94
BR - Brasile 70
NL - Olanda 69
UA - Ucraina 67
RU - Federazione Russa 64
BD - Bangladesh 52
IE - Irlanda 51
KR - Corea 48
CI - Costa d'Avorio 36
BG - Bulgaria 32
JP - Giappone 32
ZA - Sudafrica 30
CA - Canada 28
TG - Togo 28
EE - Estonia 27
FI - Finlandia 27
BE - Belgio 23
JO - Giordania 22
TH - Thailandia 22
CH - Svizzera 15
ID - Indonesia 14
SC - Seychelles 14
PL - Polonia 13
AR - Argentina 11
AT - Austria 11
ES - Italia 11
IQ - Iraq 11
PH - Filippine 11
TR - Turchia 10
EG - Egitto 8
IR - Iran 7
MX - Messico 7
TW - Taiwan 7
EC - Ecuador 6
NG - Nigeria 6
MY - Malesia 5
PK - Pakistan 5
SA - Arabia Saudita 5
AU - Australia 4
CL - Cile 4
PT - Portogallo 4
RO - Romania 4
UZ - Uzbekistan 4
PE - Perù 3
UY - Uruguay 3
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HR - Croazia 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
LT - Lituania 2
MA - Marocco 2
MM - Myanmar 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
HU - Ungheria 1
JM - Giamaica 1
KZ - Kazakistan 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TN - Tunisia 1
Totale 6.723
Città #
Singapore 386
Southend 311
Ashburn 292
Fairfield 277
Chandler 257
Ho Chi Minh City 185
Hanoi 173
San Jose 170
Ann Arbor 123
Woodbridge 121
Wilmington 113
Seattle 112
Hong Kong 108
Houston 102
Hefei 91
Cambridge 89
Santa Clara 88
Princeton 67
Beijing 61
Dong Ket 56
Dublin 51
Boardman 48
Bologna 42
Seoul 41
Abidjan 36
Jacksonville 35
Lauterbourg 35
Los Angeles 34
New York 33
Council Bluffs 32
Sofia 32
Nanjing 29
Haiphong 28
Lomé 28
Tokyo 28
Westminster 28
Padova 27
Hyderabad 25
Da Nang 24
Brussels 23
Amman 22
Buffalo 22
Berlin 20
Dallas 20
Frankfurt am Main 19
Shenyang 19
Helsinki 18
San Diego 17
Milan 16
Bern 14
Turin 13
Bremen 12
Jinan 12
Biên Hòa 11
London 11
Redondo Beach 11
Saint Petersburg 11
Bangkok 10
Chicago 10
Hải Dương 10
Munich 10
Rome 10
Tianjin 10
Toronto 10
Hebei 9
Ninh Bình 9
Amsterdam 8
Jakarta 8
Quận Bình Thạnh 8
Redwood City 8
Bengaluru 7
Changsha 7
Des Moines 7
Guangzhou 7
Hangzhou 7
Jiaxing 7
Orem 7
Shanghai 7
Stockholm 7
São Paulo 7
Warsaw 7
Falkenstein 6
Ha Long 6
Haikou 6
Mülheim 6
Ottawa 6
Vienna 6
Wuhan 6
Yubileyny 6
Zhengzhou 6
Abeokuta 5
Baghdad 5
Boston 5
Cairo 5
Chennai 5
Cosenza 5
Hamm 5
Kunming 5
Lappeenranta 5
Mahé 5
Totale 4.410
Nome #
IL-18 and VEGF-A trigger type 2 innate lymphoid cell accumulation and pro-tumoral function in chronic myeloid leukemia 386
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 258
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. 253
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 235
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 230
Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients 229
Immunosenescence and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach 216
Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib. 208
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 208
The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. 201
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 198
The Human Mesenchymal Stromal Cell-Derived Osteocyte Capacity to Modulate Dendritic Cell Functions Is Strictly Dependent on the Culture System 197
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 196
Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells 190
Extracellular ATP induces apoptosis through P2X7R activation in acute myeloid leukemia cells but not in normal hematopoietic stem cells 188
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients 188
Phospholipase C beta1 (PI-PLCbeta1)/Cyclin D3/protein kinase C (PKC) alpha signaling modulation during iron-induced oxidative stress in myelodysplastic syndromes (MDS) 188
The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling 187
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response 186
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. 186
Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells 184
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. 182
Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation 180
Corrigendum: Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells (Front. Oncol, (2020), 10, (1225), 10.3389/fonc.2020.01225) 180
The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology. 172
The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling 171
Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages. 168
Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12 and increases the homing capacity and production of proinflammatory cytokines. 166
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 165
Purinergic signaling inhibits human acute myeloblastic leukemia cell proliferation, migration, and engraftment in immunodeficient mice. 160
Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells. 159
Obesity may accelerate the aging process 156
Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells 152
The Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Regulates the Function and Migration of Leukemic Blasts through CD63/PI3K/AKT/P21 Axis 134
The sixth sense: Hematopoietic Stem Cells detect danger through purinergic signalling. 125
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor 47
Totale 6.829
Categoria #
all - tutte 17.068
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.068


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 0 0 120
2021/2022743 62 31 50 55 62 33 18 37 32 53 158 152
2022/2023794 114 137 43 118 43 64 23 33 121 12 43 43
2023/2024197 17 21 10 36 14 52 13 2 7 10 8 7
2024/2025857 49 109 54 88 128 43 41 32 26 85 49 153
2025/20262.479 398 173 169 190 212 119 211 113 532 175 87 100
Totale 6.829